Home/Pipeline/MIMICS Clinical Registry Programme

MIMICS Clinical Registry Programme

Post-market surveillance & real-world evidence for BioMimics 3D Stent

Post-MarketActive

Key Facts

Indication
Post-market surveillance & real-world evidence for BioMimics 3D Stent
Phase
Post-Market
Status
Active
Company

About Veryan Medical

Veryan Medical is a commercial-stage medical device company focused on revolutionizing peripheral artery disease (PAD) treatment through its proprietary BioMimics 3D helical stent technology. The stent's design, based on pioneering research from Imperial College London, aims to improve long-term patency by promoting beneficial swirling blood flow, which may reduce restenosis and stent failure. With FDA and CE Mark approvals, the company is commercializing its flagship product, supported by a growing body of clinical evidence from its MIMICS registry program. As part of Otsuka Medical Devices, Veryan leverages the resources of a larger healthcare group to expand its market reach.

View full company profile